Kezar Life Sciences, Inc. — Director's Dealing 2021

Jan 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2021-01-08

Reporting Person: Henig Noreen (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-08	Employee Stock Option (right to buy)	$5.45	A	280000	Acquired	2031-01-07	Common Stock (280000)	Direct

Footnotes

F1: One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.